Navigation Links
Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
Date:5/15/2008

NEW YORK and BARCELONA, Spain, May 15 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX), and Laboratorios Almirall, S.A. (ALM.MC) will host a webcast to discuss aclidinium bromide clinical and pre-clinical data findings presented at the American Thoracic Society Annual Congress. The webcast, which will include a slide presentation and a Q&A session, will occur on Wednesday, May 21, 2008 at 9:30am New York time, 3:30pm CET, 2:30pm UKT.

(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )

Representing Almirall will be Per-Olof Andersson, Executive Director, Research and Development, Gonzalo de Miquel, Global Medical Director and Jordi Beleta, Director of Biology of Almirall. Representing Forest Laboratories will be Dr. Lawrence Olanoff, President and Chief Operating Officer of Forest.

The webcast can be accessed at the URL: http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=83198&eventID=1853706 (Due to the length of the link, please copy and paste into your browser.)

Live audio-only access to the webcast can be obtained by dialing the following phone numbers:

For U.S. participants: 866.831.6162

For all international participants: +617.213.8852

The webcast will be available on Forest Laboratories' and Almirall's websites at http://www.frx.com and http://www.almirall.com the same date.

A replay of the webcast will be available on both websites.

An audio-only replay will be available until May 28, 2008 and can be accessed by dialing the following phone numbers: The passcode is 52634048

For U.S. participants: 888-286-8010

For all international participants: + 617-801-6888


'/>"/>
SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
2. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
3. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
4. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
5. Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome
6. BioSpace Launches 3rd Edition of BioForest(TM) Bioscience Marketing Campaign
7. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
8. Nanotube forests grown on silicon chips for future computers, electronics
9. Forest Laboratories Lexapro and Generics-Dominated Fluoxetine Lead First-Line Therapy in the Treatment for Major Depression
10. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
11. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Genetics Center (RGC), U.K. Biobank and GSK to generate genetic ... Biobank resource. The initiative will enable researchers to gain valuable ... for a wide range of serious and life threatening diseases. ... Genetic ...
(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017 ... announced that it has eclipsed the 130 million covered ... Cross Blue Shield of Texas . ... stages, the Company continues to enjoy strong payor acceptance ... of its clinical programs and genetic counseling, its industry-leading ...
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com ... ... cancer conditions are being pressured as of late due to ... cancer pain management has a dramatic impact on patient,s quality ... and development activities for identifying new forms of opioid formulations ...
(Date:3/22/2017)... ... ... Premier executive recruitment firm, Slone Partners, is proud to have been named a ... , Hunt Scanlon Media is one of the most respected life science publications in ... capital sector. , “It is a great honor for Slone Partners to be part ...
Breaking Biology Technology:
(Date:3/23/2017)... , Mar. 23, 2017 Research and Markets ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 8.8% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
(Date:3/20/2017)... 2017 At this year,s CeBIT Chancellor Dr. ... DERMALOG. The Chancellor came to the DERMALOG stand together with the Japanese ... CeBIT partner country. At the largest German biometrics company the two government ... and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... MELBOURNE , Australia , March ... clinical study data at the prestigious World Lung Imaging ... Dr. Andreas Fouras , was invited to deliver ... and pulmonary medicine. This globally recognised event brings together ... and share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):